TOOLS FOR GENETIC MAPPING IN YEAST
酵母基因图谱工具
基本信息
- 批准号:2900920
- 负责人:
- 金额:$ 9.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 2001-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Dr. David Stillman proposed to develop a portable, rapid mapping system
for the yeast Saccharomyces cerevisiae. The primary use for this system
will be map mutations that have proved difficult to clone by
complementation; it would provide the information necessary for
positional mapping.
The development of the system will proceed in two phases. The first
phase involves the construction of sixteen plasmids each of which will
be targeted to integrate near the centromere of one of the yeast
chromosomes. These plasmids will carry a GAL1 promoter that when
activated would transcribe through the centromere, inactivating it and
causing chromosome loss. The plasmids also will contain a dominant
marker that would allow easy scoring for such a loss. Using these
plasmids, a researcher could construct sixteen strains with a specific
genetic background, each carrying one of these plasmids in a different
chromosome. Each strain could then be mated with the mutant strain, and
the loss of the plasmid containing chromosome in each diploid would be
induced. In one of the diploid strains, the recessive mutant phenotype
would be uncovered when the chromosome carrying the wildtype allele was
lost, thus mapping the mutation to that chromosome. The second phase
of development involves the construction of a set of 35 chromosome
fragmentation vectors. These plasmids will allow a researcher to divide
the larger chromosomes into two or three fragments to map the mutation
of interest to a subchromosomal segment. Each plasmids will carry a
centromere joined to a GAL1 promoter, suitable selectable markers, and
a region to which integration is targeted, all contained between
telomeric sequences. The restriction enzyme SceI flanked by sites for
this enzyme will be inserted between the telomeric sequences opposite
the rest of the vector. The integration of this vector at the targeted
site will generate an unstable dicentromeric chromosome. The
instability will be resolved through cleavage by SceI (which does not
cleave nuclear DNA), cutting the chromosome in two between the
centromeres. The presence of the telomeric sequences will generate
proper ends. Thus, the targeted chromosome will be cut in two at the
chosen site. One of the new chromosomes will contain the centromere
that can be inactivated when the GAL1 promoter is induced, causing its
loss and exposing the recessive mutation if the wildtype allele were
contained within that chromosomal segment. Thus, once a mutation is
mapped to a particular chromosome, that chromosome could be fragmented
to determine which fragment contains the mutation.
Once a gene is mapped to a region of a chromosome, complementation could
be tested using clones from that region.
大卫斯蒂尔曼博士建议开发一种便携式快速绘图系统
酿酒酵母 该系统的主要用途是
将是已经证明很难克隆的地图突变,
补充;它将提供必要的信息,
位置映射
该系统的开发将分两个阶段进行。 第一
阶段涉及16个质粒的构建,每个质粒将
被靶向整合到一个酵母的着丝粒附近,
染色体 这些质粒将携带GAL 1启动子,
激活后会通过着丝粒转录,使其失活,
导致染色体丢失。 质粒也将包含一个显性的
这样的损失很容易得分的标记。 使用这些
质粒,研究人员可以构建16个菌株,
基因背景,每个携带这些质粒中的一个在不同的
染色体 然后每个菌株可以与突变菌株交配,
每个二倍体中含有染色体的质粒的丢失将是
诱导。在其中一个二倍体菌株中,隐性突变表型
当携带野生型等位基因的染色体
丢失,从而将突变映射到该染色体。 第二阶段
发育的一个重要步骤是构建一套35条染色体
碎片化载体。 这些质粒可以让研究人员
将较大的染色体分成两到三个片段,
与亚染色体片段相关。 每一个质粒都会携带一个
连接到GAL 1启动子的着丝粒,合适的选择标记,和
整合的目标区域,所有包含在
端粒序列 限制性内切酶SceI的两侧是
该酶将插入相对的端粒序列之间
剩下的向量。 该载体在靶向
位点将产生不稳定的双着丝粒染色体。 的
不稳定性将通过SceI的裂解来解决(SceI不
切割核DNA),将染色体在两个细胞之间切割成两个。
着丝粒 端粒序列的存在会产生
适当的结束。因此,靶向染色体将在染色体的末端被切成两半。
选择的网站 其中一条新染色体将包含着丝粒
当GAL 1启动子被诱导时,它可以被灭活,
如果野生型等位基因是
包含在染色体片段中。因此,一旦突变发生,
映射到一个特定的染色体上,
以确定哪个片段含有突变。
一旦一个基因被定位到染色体的某个区域,互补作用就可以
使用该地区的克隆进行测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J Stillman其他文献
David J Stillman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J Stillman', 18)}}的其他基金
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 9.17万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 9.17万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 9.17万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 9.17万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 9.17万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 9.17万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 9.17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 9.17万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 9.17万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 9.17万 - 项目类别: